SSA
AVXL icon

Schonfeld Strategic Advisors’s Anavex Life Sciences AVXL Stock Holding History

Schonfeld Strategic Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-46,195
Closed -$164K – 2217
2025
Q4 		$164K Buy
+46,195
New +$283K ﹤0.01% 1748
2023
Q4 		– Sell
-26,287
Closed -$172K – 1871
2023
Q3 		$172K Buy
26,287
+10,604
+68% +$84.4K ﹤0.01% 1438
2023
Q2 		$128K Buy
+15,683
New +$134K ﹤0.01% 1675
2022
Q4 		– Sell
-93,045
Closed -$960K – 2585
2022
Q3 		$960K Buy
93,045
+76,246
+454% +$805K 0.01% 1298
2022
Q2 		$168K Buy
+16,799
New +$159K ﹤0.01% 1963

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM